Hope and Concern

To some people, three-person IVF or mitochondrial replacement is hope for preventing mitochondrial diseases from being passed on to the next generation, while to others, it is the beginning of the development of designer babies, the New York Times Magazine says.

In the US, the Food and Drug Administration regulates this technique, and recently held a hearing to consider allowing clinical trials of mitochondrial replacement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.